IgG4-related disease: an update on pathophysiology and implications for clinical care
Top Cited Papers
- 16 September 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Rheumatology
- Vol. 16 (12), 702-714
- https://doi.org/10.1038/s41584-020-0500-7
Abstract
IgG4-related disease (IgG4-RD) has only existed as a unique disease entity since 2003, yet remarkable progress has already been achieved in describing the essential features of the disease. A framework for systematic clinical studies has been created by the development of a quantitative disease activity tool (the IgG4-RD Responder Index) and the validation of classification criteria, both of which were the products of international, multi-centre investigations. In addition, substantial strides have been made in understanding the pathophysiology of IgG4-RD. In particular, the central role of B cells in the disease has been demonstrated by both the robust clinical responsiveness of IgG4-RD to B cell depletion and by the identification of multiple self-antigens that promote B cell expansion. CD4+ T cells have also been investigated in detail; CD4+ cytotoxic T lymphocytes (suspected of promoting disease) and a specific T follicular helper cell subset that contributes to IgG4 isotype switching have both been defined by multiple groups. The mechanisms by which these immune cells converge on target tissues, interact with fibroblasts and promote tissue remodelling are beginning to be understood and will be an important research focus in the coming years.Keywords
This publication has 104 references indexed in Scilit:
- Mouse model recapitulating human Fcγ receptor structural and functional diversityProceedings of the National Academy of Sciences of the United States of America, 2012
- Analysis of IgG4 class switch-related molecules in IgG4-related diseaseArthritis Research & Therapy, 2012
- Rituximab for the Treatment of IgG4-Related DiseaseMedicine, 2012
- A novel clinical entity, IgG4-related disease (IgG4RD): general concept and detailsModern Rheumatology, 2011
- Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactionsNature Medicine, 2011
- Foxp3+ follicular regulatory T cells control the germinal center responseNature Medicine, 2011
- Human Blood CXCR5+CD4+ T Cells Are Counterparts of T Follicular Cells and Contain Specific Subsets that Differentially Support Antibody SecretionImmunity, 2011
- Autoantibodies Against the Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression Profiling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the Inflammatory ProcessThe American Journal of Gastroenterology, 2010
- Amylase α-2A AutoantibodiesDiabetes, 2009
- Wegener Granulomatosis: An Analysis of 158 PatientsAnnals of Internal Medicine, 1992